Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness;Suivi comparé d'un échantillon sentinelle et de la population quant à l'efficacité du vaccin conjugué contre le pneumocoque

Bulletin of the World Health Organization

Volumn 90, Issue 8, 2012, Pages 568-577

  Hampton, Lee M ^a   Zell, Elizabeth R ^a   Schrag, Stephanie ^a   Cohen, Adam L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

CHILD; DISEASE CONTROL; DISEASE INCIDENCE; HOSPITAL SECTOR; PNEUMONIA; VACCINE;

AGE DISTRIBUTION; ARTICLE; CHILD; COMPARATIVE STUDY; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; SENTINEL SURVEILLANCE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

CHILD, PRESCHOOL; HUMANS; INCIDENCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SENTINEL SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; UNITED STATES; VACCINES, CONJUGATE;

UNITED STATES;

STREPTOCOCCUS PNEUMONIAE;

EID: 84864499425     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.098178     Document Type: Article

References (30)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893-902. doi:10.1016/S0140-6736(09)61204-6 PMID:19748398
2. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-1746. doi:10.1056/NEJMoa022823 PMID:12724479
3. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010;201:32-41. doi:10.1086/648593 PMID:19947881
4. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the Gambia: randomised, double-blind, placebo controlled trial. Lancet 2005;365:1139-1146. doi:10.1016/S0140-6736(05)71876-6 PMID:15794968
5. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-1348. doi:10.1056/NEJMoa035060 PMID:14523142
6. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007;82:93-104. PMID:17380597
7. Knoll MD, Moisi JC, Muhib FB, Wonodi CB, Lee EH, Grant L., et al. Standardizing surveillance of pneumococcal disease. Clin Infect Dis 2009;48:S37-S48. doi:10.1086/596480 PMID:19191618
8. Lynfield R, Van Beneden CA. Public health surveillance for infectious diseases. In: Lee LM, Teutsch SM, Thacker SB, St Louis ME, editors. Principles and practice of public health surveillance, 3rd edn. Oxford: Oxford University Press; 2010. pp. 236-254.
9. Global framework for immunization monitoring and surveillance. Geneva: World Health Organization; 2007.
10. Schrag SJ, Zell ER, Schuchat A, Whitney CG. Sentinel surveillance: a reliable way to track antibiotic resistance in communities? Emerg Infect Dis 2002;8:496-502.PMID:11996685
11. Montana LS, Mishra V, Hong R. Comparison of HIV prevalence estimates from antenatal care surveillance and population surveillance surveys in sub-Saharan Africa. Sex Transm Infect 2008;84:i78-i84. doi:10.1136/sti.2008.030106 PMID:18647871
12. Schuchat A, Hilger T, Zell ER, Farley MM, Reingold A, Harrison L., et al. Active Bacterial Core surveillance of the emerging infections program network. Emerg Infect Dis 2001;7:92-99. doi:10.3201/eid0701.010114 PMID:11266299
13. US census populations with bridged race categories [Internet]. Atlanta: Centers for Disease Control and Prevention; 2011. Available from: http://www.cdc.gov/nchs/nvss/bridged_race.htm [accessed 28 March 2012].
14. Levine OS, Cherian T, Hajjeh R, Knoll MD. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis 2009;48:S33-S36. doi:10.1086/596479 PMID:19191617
15. Kisakye A, Makumbi I, Nansera D, Lewis R, Braka F, Wobudeya E., et al. Surveillance for Streptococcus pneumoniae meningitis in children aged <5 years: implications for immunization in Uganda. Clin Infect Dis 2009;48:S153-S161. doi:10.1086/596495 PMID:19191611
16. Saha SK, Naheed A, El Arifeen S, Islam M, Al-Emran H, Amin R., et al. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clin Infect Dis 2009;48:S75-S81. doi:10.1086/596544 PMID:19191622
17. Batuwanthudawe R, Karunarathne K, Dassanayake M, de Silva S, Lalitha MK, Thomas K., et al. Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin Infect Dis 2009;48:S136-S140. doi:10.1086/596492 PMID:19191609
18. Williams EJ, Thorson S, Maskey M, Mahat S, Hamaluba M, Dongol Set al. Hospital-based surveillance of invasive pneumococcal disease among young children in urban Nepal. Clin Infect Dis 2009;48:S114-S122. doi:10.1086/596488 PMID:19191606
19. Shah AS, Knoll MD, Sharma PR, Moisi JC, Kulkarni P, Lalitha MK., et al. Invasive pneumococcal disease in Kanti Children's Hospital, Nepal, as observed by the South Asian Pneumococcal Alliance network. Clin Infect Dis 2009;48:S123-S128.doi:10.1086/596490 PMID:19191607
20. Falade AG, Lagunju IA, Bakare RA, Odekanmi AA, Adegbola RA. Invasive pneumococcal disease in children aged < 5 years admitted to 3 urban hospitals in Ibadan, Nigeria. Clin Infect Dis 2009;48:S190-S196. doi:10.1086/596500 PMID:19191615
21. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S., et al. Elimination of Haemophilus influenzae type b (Hib) disease from the Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005;366:144-150. doi:10.1016/S0140-6736(05)66788-8 PMID:16005337
22. von Gottberg A, de Gouveia L, Madhi SA, du Plessis M, Quan V, Soma K., et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ 2006;84:811-818. doi:10.2471/BLT.06.030361 PMID:17128361
23. Gessner BD, Adegbola RA. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines. Vaccine 2008;26(Suppl 2):B3-B8. doi:10.1016/j.vaccine.2008.04.013 PMID:18793604
24. Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R etal. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010;7:e1000348. doi:10.1371/journal.pmed.1000348 PMID:20957191
25. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007;196:1346-1354. doi:10.1086/521626 PMID:17922399
26. Morais L, Carvalho Mda G, Roca A, Flannery B, Mandomando I, Soriano-Gabarro M., et al. Sequential multiplex PCR for identifying pneumococcal capsular serotypes from South-Saharan African clinical isolates. J Med Microbiol 2007;56:1181-1184. doi:10.1099/jmm.0.47346-0 PMID:17761480
27. Dias CA, Teixeira LM, Carvalho Mda G, Beall B. Sequential multiplex PCR for determining capsular serotypes of pneumococci from Brazilian children. J Med Microbiol 2007;56:1185-1188. doi:10.1099/jmm.0.47347-0 PMID:17761481
28. Njanpop Lafourcade BM, Sanou O, van der Linden M, Levina N, Karanfil M, Yaro S et al. Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid. J Clin Microbiol 2010;48:612-614. doi:10.1128/JCM.01402-09 PMID:20007384
29. Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H., et al. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008;26:3277-3281. doi:10.1016/j.vaccine.2008.03.087 PMID:18456376
30. Amos B, Kisakye A, Makewa D, Mudhune S, Mwamtemi H, Nansera D., et al. Behind the data: establishing the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin Infect Dis 2009;48(Suppl 2):S162-S171. doi:10.1086/596496 PMID:19191612